Surgginex Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 11 Year, 5 Days
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2019)
- Profit -26.41%
(FY 2019)
- Ebitda -33.33%
(FY 2019)
- Net Worth -0.64%
(FY 2019)
- Total Assets
About Surgginex Lifesciences
The Corporate was formerly known as Surgginex India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Zameer Rais and Nahida Rais serve as directors at the Company.
- CIN/LLPIN
U33119MH2013PTC251227
- Company No.
251227
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2013
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Surgginex Lifesciences Private Limited offer?
Surgginex Lifesciences Private Limited offers a wide range of products and services, including Dentist Tools, Equipment & Supplies, Dental Equipment.
Who are the key members and board of directors at Surgginex Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Zameer Rais  | Director | 19-Dec-2013 | Current |
| Nahida Rais | Director | 19-Dec-2013 | Current |
Financial Performance of Surgginex Lifesciences.
Surgginex Lifesciences Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 26.41% decrease in profit. The company's net worth dipped by a decrease of 0.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surgginex Lifesciences?
In 2017, Surgginex Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Promax Health Foods Private LimitedActive 9 years 1 monthZameer Rais and Nahida Rais are mutual person
Ennovex Technologies Private LimitedActive 9 years 9 monthsZameer Rais and Nahida Rais are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Surgginex Lifesciences?
Unlock and access historical data on people associated with Surgginex Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surgginex Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surgginex Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
